Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG)

Journal of Cellular Biochemistry

Volumn 89, Issue 6, 2003, Pages 1222-1234

  Wȩsierska Ga̧dek, Józefa ^a   Gueorguieva, Marieta ^a   Schloffer, Daniela ^a   Uhl, Maria ^a   Wojciechowski, Jacek ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

AIF translocation; Apoptosis; Caspase 3 activation; Comet assay; Cytochrome c; Degradation of PARP 1; Inactivation of PARP 1; Necrosis; P53 activation; Single cell gel electrophoresis

Indexed keywords

ALKYLATING AGENT; CASPASE 3; CISPLATIN; CYTOCHROME C; DPQ; ETOPOSIDE; METHYLNITRONITROSOGUANIDINE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL DEATH; CELL KILLING; CELL SUBPOPULATION; CHROMATIN CONDENSATION; CHROMATIN FRAGMENTATION; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME INACTIVATION; FLOW CYTOMETRY; GENOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRION; NICK END LABELING; PRIORITY JOURNAL; STAINING;

ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL MEMBRANE; CISPLATIN; COMET ASSAY; FLOW CYTOMETRY; HELA CELLS; HUMANS; IMMUNOBLOTTING; METHYLNITRONITROSOGUANIDINE; POLY(ADP-RIBOSE) POLYMERASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042195867     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10586     Document Type: Article

References (30)

1. Berger NA. 1985. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 101:4-15.
2. Blagosklonny MV. 2002. p53: An ubiquitous target of anticancer drugs. Int J Cancer 98:161-166.
3. Christmann M, Kaina B. 2000. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells at alkylating agents. J Biol Chem 275:36256-36262.
4. Durst M, Croce CM, Gissmann L, Schwarz E, Huebner K. 1987. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 84:1070-1074.
5. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
6. Fiers W, Beyaert R, Declercq W, Vandenabeele P. 1999. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 18:7719-7730.
7. Fiskum G, Kowaltowksi AJ, Andreyev AY, Kushnareva YE, Starkov AA. 2000. Apoptosis-related activities measured with isolated mitochondria and digitonin-permeabilized cells. Methods Enzymol 322:222-234.
8. Heck DV, Yee CL, Howley PM, Munger K. 1992. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci USA 89:4442-4446.
9. Helma C, Uhl M. 2000. A public domain image analysis program for the single cell gel electrophoresis (Comet) assay. Mutat Res 466:9-15.
10. Horky M, Wurzer G, Kotala V, Anton M, Vojtesek B, Vacha J, Wesierska-Gadek J. 2001. Segregation of nucleolar components coincides with caspase-3 activation in cisplatin-treated HeLa cells. J Cell Sci 114:663-670.
11. Kaina B, Ochs K, Grötsch S, Fritz G, Lips J, Tomicic M, Dunkern T, Christmann M. 2001. BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucl Acid Res Mol Biol 68:41-54.
12. Kumari SR, Mendoza-Alvarez H, Alvarez-Gonzalez R. 1998. Functional interaction of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the Mr 85,000 proteolytic fragment. Cancer Res 58:5075-5078.
13. Lövborg H, Wojciechowski J, Larsson R, Wesierska-Gadek J. 2002. Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: Increased sensitivity of cells lacking poly(ADP-ribose) polymerase-1. Cancer Res 62:4206-4211.
14. 6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res 60:5815-5824.
15. Olson M, Kornbluth S. 2001. Mitochondria in apoptosis and human disease. Curr Mol Med 1:91-122.
16. 6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int J Cancer 65:506-512.
17. Roser S, Pool-Zobel B-L, Rechkemmer G. 2001. Contribution of apoptosis to responses in the comet assay. Mut Res 497:169-175.
18. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
19. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
20. Sherr CJ, McCormick F. 2002. The RB and p53 pathways in cancer. Cancer Cell 2:103-112.
21. Singh NP, McCoy M, Tice RR, Schneider E. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
22. Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, Cho KR. 1994. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91:5320-5324.
23. Tamm I, Schriever F, Dorken B. 2001. Apoptosis: Implications of basic research for clinical oncology. Lancet Oncol 2:33-42.
24. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000. Single cell gel/Comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-221.
25. Vermes I, Haanen C. 1994. Apoptosis and programmed cell death in health and disease. Adv Clin Chem 31:177-246.
26. Vindelov LL, Christensen IJ, and Nissen NI. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327.
27. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF. 1995. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9:509-520.
28. 1 checkpoint. J Cell Biochem 80:85-103.
29. Wesierska-Gadek J, Schloffer D, Kotala V, Horky M. 2002. Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int J Cancer 101:128-136.
30. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. 2002. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297:259-263.